A detailed history of Regal Investment Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Regal Investment Advisors LLC holds 4,588 shares of LLY stock, worth $3.65 Million. This represents 0.29% of its overall portfolio holdings.

Number of Shares
4,588
Previous 5,323 13.81%
Holding current value
$3.65 Million
Previous $4.82 Million 15.67%
% of portfolio
0.29%
Previous 0.32%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$772.14 - $960.02 $567,522 - $705,614
-735 Reduced 13.81%
4,588 $4.06 Million
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $11,597 - $14,544
16 Added 0.3%
5,323 $4.82 Million
Q1 2024

May 15, 2024

BUY
$592.2 - $792.28 $295,507 - $395,347
499 Added 10.38%
5,307 $4.13 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $737,891 - $869,877
1,405 Added 41.29%
4,808 $2.8 Million
Q3 2023

Nov 13, 2023

BUY
$434.7 - $599.3 $64,335 - $88,696
148 Added 4.55%
3,403 $1.83 Million
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $165,900 - $221,827
473 Added 17.0%
3,255 $1.53 Million
Q1 2023

May 11, 2023

SELL
$310.63 - $364.82 $139,783 - $164,169
-450 Reduced 13.92%
2,782 $955,000
Q4 2022

Mar 01, 2023

SELL
$321.55 - $374.67 $87,140 - $101,535
-271 Reduced 7.74%
3,232 $1.18 Million
Q3 2022

Nov 15, 2022

BUY
$296.48 - $337.87 $98,727 - $112,510
333 Added 10.5%
3,503 $1.13 Million
Q2 2022

Aug 09, 2022

BUY
$278.73 - $327.27 $178,944 - $210,107
642 Added 25.4%
3,170 $1.03 Million
Q1 2022

May 09, 2022

BUY
$234.69 - $291.66 $2,112 - $2,624
9 Added 0.36%
2,528 $723,000
Q4 2021

Feb 10, 2022

BUY
$224.85 - $279.04 $30,579 - $37,949
136 Added 5.71%
2,519 $696,000
Q3 2021

Nov 05, 2021

BUY
$221.6 - $272.71 $8,199 - $10,090
37 Added 1.58%
2,383 $551,000
Q2 2021

Aug 09, 2021

BUY
$180.55 - $233.54 $423,570 - $547,884
2,346 New
2,346 $538,000
Q1 2021

May 12, 2021

SELL
$164.32 - $212.72 $324,532 - $420,122
-1,975 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $257,658 - $340,944
1,975 New
1,975 $333,000
Q3 2020

Nov 13, 2020

SELL
$146.22 - $169.13 $603,742 - $698,337
-4,129 Closed
0 $0
Q2 2020

Aug 03, 2020

BUY
$136.42 - $164.18 $563,278 - $677,899
4,129 New
4,129 $678,000
Q2 2019

Jul 26, 2019

SELL
$110.79 - $129.32 $175,048 - $204,325
-1,580 Closed
0 $0
Q1 2019

May 09, 2019

SELL
$111.31 - $131.02 $91,942 - $108,222
-826 Reduced 34.33%
1,580 $205,000
Q4 2018

Feb 04, 2019

SELL
$105.9 - $118.64 $71,800 - $80,437
-678 Reduced 21.98%
2,406 $278,000
Q3 2018

Nov 05, 2018

BUY
$85.86 - $107.31 $264,792 - $330,944
3,084 New
3,084 $331,000
Q2 2018

Aug 10, 2018

SELL
$75.7 - $86.88 $231,793 - $266,026
-3,062 Closed
0 $0
Q1 2018

Apr 25, 2018

BUY
$74.21 - $87.6 $30,277 - $35,740
408 Added 15.37%
3,062 $237,000
Q4 2017

Feb 06, 2018

SELL
$81.94 - $87.89 $20,812 - $22,324
-254 Reduced 8.73%
2,654 $224,000
Q3 2017

Nov 08, 2017

BUY
$77.07 - $85.54 $224,119 - $248,750
2,908
2,908 $249,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Regal Investment Advisors LLC Portfolio

Follow Regal Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Regal Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Regal Investment Advisors LLC with notifications on news.